A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.

2025-2026 Regular Session Introduced by Tony Bisignano

Bill SF 202 mandates accessible prescription materials for individuals with visual impairments, improving their access to essential health information and requiring pharmacies to adapt.

Subcommittee: Klimesh, Costello, and Petersen.

#administrativerules #blindness #disabilities #drugs #health-relatedprofessions #labels #pharmacy #prescriptiondrugs #reports

Purpose and Intent

Bill SF 202 aims to enhance accessibility for individuals who are blind, have visual impairments, or possess other print disabilities by ensuring the provision of accessible prescription-related materials. The bill seeks to address the challenges these individuals face in accessing essential health information related to prescription drugs.

Key Provisions

Accessible Prescription Materials: The bill mandates the development and implementation of rules that ensure accessible prescription drug labels, bag tags, and medical guides tailored for individuals with visual impairments or print disabilities.

Reporting Requirements: The Board is required to submit a report to the Governor and the General Assembly by January 1, 2026. This report will include:

Progress on the implementation of the accessibility rules.
Recommendations for additional measures to improve accessibility.
Projected costs associated with implementing enhanced dispensing fees to support the provision of accessible materials.

Enhanced Dispensing Fees: The bill proposes the introduction of enhanced dispensing fees to help cover the costs of providing accessible prescription-related materials.

Affected Parties

Individuals with Disabilities: The primary beneficiaries of this bill are persons who are blind, have visual impairments, or have print disabilities, as they will gain improved access to critical health information.

Pharmacies and Health Professionals: Pharmacies and health-related professionals will be required to adapt their practices to comply with the new accessibility standards, which may involve additional training and resources.

Procedural Aspects

Introduced Date: The bill was introduced on February 4, 2025.

Subcommittee Review: As of February 11, 2025, the bill has been assigned to a subcommittee consisting of members Klimesh, Costello, and Petersen for further review and discussion.

Legislative Classification: The bill is classified under administrative rules related to health, disabilities, and pharmacy practices.

Conclusion

Bill SF 202 represents a significant step towards improving healthcare accessibility for individuals with disabilities. By mandating the provision of accessible prescription-related materials and establishing a framework for implementation and reporting, the bill aims to ensure that all individuals, regardless of their visual capabilities, can access vital health information. The anticipated report due in early 2026 will provide further insights into the progress and effectiveness of these measures.

Bill